{
    "clinical_study": {
        "@rank": "137917", 
        "arm_group": {
            "arm_group_label": "Sunbed", 
            "arm_group_type": "Active Comparator", 
            "description": "sunbed exposure"
        }, 
        "brief_summary": {
            "textblock": "Our study aims to clarify the impact of the use of a standard sunbed according to new EU\n      guideline EN 60335-2-27 and possibly discount the positive effects of tanning beds. We plan\n      to investigate the serum elevation of 25(OH)D under sunbed use, respecting the new\n      recommendations for the exposure plan for different skin types according to EN 60335-2-27.\n\n      The use of a sunbed will be compared to a control group not using a sunbed in the\n      observation period.\n\n        -  Trial with medical device"
        }, 
        "brief_title": "Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Skin Toxicity", 
        "detailed_description": {
            "textblock": "We will compare to baseline changes in serum vitamin D and health-related quality of life\n      using a control group and an intervention group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria: Probands intending to use a commercial sunbed :\n\n          1. Age 18 years or older\n\n          2. Regular use of commercial sunbeds\n\n          3. Oral and written informed consent\n\n        Exclusion criteria: 1. Skin type I according to Fitzpatrick according to EU guideline EN\n        60335-2-27 2. Sunbed use within the last three months 3. Use of vitamin D supplements or\n        multivitamin supplements 4. Any medical condition which renders them unfit for sunbed use\n        in the judgment of the investigator 5. Inability to provide oral and written consent to\n        participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976481", 
            "org_study_id": "sunbed study"
        }, 
        "intervention": {
            "arm_group_label": "Sunbed", 
            "description": "exposure to sunbed ultraviolet radiation", 
            "intervention_name": "sunbed exposure", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin D", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Division of Dermatology"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Serum 25-OH Vitamin D Modulation by Sunbed Use According to EU Guideline EN 60335-2-27", 
        "overall_contact": {
            "email": "hofbauer@usz.ch", 
            "last_name": "Guenther Hofbauer, Prof MD"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Division of Dermatology", 
            "last_name": "Guenther Hofbauer, Prof MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Determination of number of patients with a relevant elevation of serum 25-hydroxyvitamin D levels of =10ug/L from the baseline", 
            "safety_issue": "No", 
            "time_frame": "six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976481"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}